Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Myo Maung Maung Swe and Htet Htet Aung from our MOCRU unit in Myanmar were awarded grants by the International Society for Infectious Diseases and Wellcome. Myo Maung will study antibiotics use and antimicrobial resistance public awareness in Myanmar; Htet Htet will conduct a study on Ethical challenges when offering pregnant women with Hepatitis B short course treatment to prevent transmission.

Dr Myo Maung Maung Swe and Htet Htet Aung

Dr Myo Maung Maung Swe (left), Clinical Researcher and DPhil student at MOCRU, was awarded in August an International Society for Infectious Diseases (ISID) research grant, a signature ISID program that funds infectious disease researchers from LMIC countries with the greatest burden of infectious disease. Myo Maung, a clinical researcher at MOCRU for 3 years, was awarded the ISID research grant to conduct the study Antibiotics use and antimicrobial resistance (AMR) public awareness survey in Myanmar. Myo plans to conduct the study, which aims to understand self-reported antibiotic use, public knowledge of antibiotics and the awareness of antibiotic resistance, in two regions of Myanmar, as yet to be determined. The team will collect data Dec 2018-Jan 2019 and hopes to publish results by April 2019.

That same month, MOCRU Clinical Research Assistant Htet Htet Aung (right) was awarded an Ethox Global Health Bioethics Network (GBHN) Bursary Award. GBHN is funded by a Wellcome Trust Strategic Award aiming to conduct ethics research and improve capacity building across the Wellcome Trust Major Overseas Programmes. Htet Htet, who has worked as a clinical research assistant in MOCRU for a year, will use the GBHN Bursary to conduct the study Ethical challenges related to offering pregnant women with chronic Hep B short course treatment with Tenofovir disoproxil fumarate to prevent vertical transmission in Myanmar. Htet Htet hopes to start the study mid-Oct, once she gets OxTREC and local Ethics Committee approval, and publish results in early June 2019. The study will be conducted at Central Women’s Hospital, Yangon.

Similar stories

Enhanced vaccination against Japanese encephalitis virus could reduce encephalitis prevalence by one third in SE Asia

Encephalitis is a worldwide public health issue, with a substantially high burden among children in Southeast Asia. A large study of the causes of childhood encephalitis in SE Asia suggests that enhanced and effective vaccination against the Japanese encephalitis virus alone could reduce encephalitis prevalence by one third.

Congratulations to Professor Sir David Warrell, appointed Knight Commander of the Order of St Michael and St George!

David Warrell, MORU founding director, has been appointed by the Queen ‘Knight Commander of the Order of St Michael and St George for services to global Health Research and Clinical Practice’. Please join us in congratulating Sir David on receiving this richly deserved high honour!

Laos’ first Pint of Science: warty newts, COVID, AI for Instagram, and more!

Organised by a grass-root community of thousands of scientists across the world, Pint of Science 2022 allows researchers in 25 countries and over 800 cities to share their latest findings with lay folk in interesting, informal settings. Lao PDR joined the global Pint of Science family on Monday 9 May, when the first-ever Pint of Science Laos kicked off!

Patient recruitment on track in Oxford-led DeTACT trial of safe, effective drug combinations to prevent the spread of artemisinin and multi-drug resistant malaria in Africa

Today is World Malaria Day. The global fight against malaria is at a critical point. No new antimalarial drugs are expected in the near future, and if multi-drug resistant falciparum malaria becomes established in East Africa and spreads to other parts of Africa, millions will be at risk of drug-resistant malaria infection and death. The development of triple artemisinin-based combination therapies aims to prevent or delay the emergence of artemisinin and multi-drug resistant malaria in Africa.

PRIORITISE study team publishes results, now seeks partners

In regions where few people have received Covid-19 vaccines, health systems remain vulnerable to surges in SARS-CoV-2 infections. During the delta-wave of COVID-19 in India, for example, healthcare facilities and staff across the country struggled to cope with the surge in the number of cases of COVID-19 due to a shortage of hospital beds for people with severe cases, plus shortages of medicines and limited human resources.

Under the Mask, drama film based on testimonies of tuberculosis patients

In 2022, tuberculosis (TB) remains a major global health problem, particularly in developing countries. On the Thai-Myanmar border, TB is an important problem among migrants, a vulnerable, very mobile population, with unstable, often difficult living conditions, insecure incomes, and poor access to health services.